OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2023-12-31-accounts

Registered number: 02339750 Charlty number: 801382 Kent ms rAer4)¥Centre KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD (A company limited by guarantee) UNAUDITED TRUSTEES. REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD (A company Ilmlted by guarantee) CONTENTS Page Reference and administrative detalls of the Companyi its Trustees and advisers Trustees. report Independent examinerfs report Statement of flnan¢ial activities 10 Balance sheet Statement of rAsh flows 12 Notes to th• financial ststements 13-30

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD IA company limited by guarantee) REFERENCE AND ADMINISTRATIVE DETAILS OF THE COMPANY. trs TRUSTEES AND ADVISERS FOR ThEYEAR ENDED 31 DECEMBER2023 Trustoos Ms S Wilding (resigned 31 January 2023) Mr D J Bailey {resigned 31 March 2024) Mrs J Tompkins Mrs H Brian (resigned 29 June 2023) Mrs l Neitsth Mr J Limmer. Chair MrA Cleur Mr P Connolly Mf I Pa(kJa {appoinled 1 January 2023, resigned 30 April 2024) Ms L Ellis (appointed 27 January 2023. resigned 30 April 2024) Ms P Kersten (appointed 30 April 2024) Mr R Manston {appointed 30 April 2024) Company rogistered number 02339750 Charity registered number 801382 Registered office Bradbury House Merton Lane {North) Canterbury Kent CT4 7DZ Company secretary Mr J Limmer Chlef executive officer Mr S Goddard (resign8d 13 August 2023) Ms H Colernan Accountants Magee Gammon Chartered Accountants Henwood House Henwood Ashford Kent TN24 8DH Page 1

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD (A company limited by guarantee) TRUSTEES. REPORT FOR THE YEAR ENDED 31 DECEMBER 2023 The Trustees present their annual report together with the fironcial statements of the Company for the year 1 January 2023 to 31 December 2023. The Annual report serves the purposes of both a Trustees. report and a directors, report under company law. The Trustees confirm that the Annual report and financial statements of the charitable company comply with the current statutory requirements, the r8quir8m8nts of the tharitable company's goveming document the provisions of the Ststement of Recommended Practice (SORP) applicable to charities preparing their accounts in accordanca with the Financial Reporting Standard applicable in the UK and R8public of Ireland (FRS102) (effedive 1 January 2019). Since the Company qualifies as small under sedon 382 of the Companies Act 2006, the Sttategic report required of medium and large companies under the Companies Act 2006 {Strategi¢ Report and Directors, Report) Regulations 2013 has been ornitted. Objectives and activltles a. Policies and objectives The charity is govemed by its M8rrM)randum and Artides of Assocaation aThJ aims to promote the relief of persons in the county of Kent who live wth Muttiple Sderosis (MS) and other neurological conditions by any lawFul means and in particular and without preNd1￿ to the generality of the foregoing.. to provide advi￿, guidance and moral and practical SUp￿rt for persons living with MS to provide therapy (Induding oxygen therapy) for persons Iving wlh MS or other similar symptoms or conditions In settlng objectives and planning for activities. the Trustees have given due considerab'on to general guidance published by th8 Charity Commission relating to public benefft, including the guidance 'Public benefrt: running a charity {PB2)'. b. Activities for achieving objectives To ensure the charitable 0)mpan￿$ aims are met. the charttable company has a general policy to bring together persons living with MS and persons interested or more widely affected by MS. The charitable company administers and equips a ￿ntre for the provision of therapies. "Active" members ar8 required to pay for mernber5hip to the centr8. thereafter ￿11 members are asked for a donation contributing to the operating costslcost of therapy and associate mernbers are required to pay a fixed charge albeit one well below the maTk8t rate. The centre also raise5 fund8 through events and dQnafj￿s. The major source of funds ￿rneS from the en0nr￿US support that th8 charity receives from Trusts and Foundations wtthout whom the centre would not exisL There have been no material thanges in these policies since the last reporL Page 2

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD (A company Ilmlted by guarantee) TRUSTEES. REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023 Achievements and perfomiance . Review of actlvltles The charitable company has conlinued its main objective of PToviding a range of therapies. support and advi to those with MS. their families and carers. 2023 was the ninth year of operation in the New Centre which continues to provid8 a slatB of the art facility to its users and consequently the prinopal therapias of High t)ose Oxygen Therapy. Physiotherapy, Reflexology. Acupunctur8 and Hydrotherapy have all ￿MaIned in strong dernand. The Centre also continues to treat a range of Th)n-MS conditions with High Dose Oxygen Therapy including some life long conditions such as fibromyalgia. Can￿r. post-operative wounds and sports injuries. the income from which assists in the subsidising of its services to members with MS. cOn￿nUal investment In Centre staff has futher strengthened the offering available to Centr8 Users. We additionally hav8 recruried 4 new TNsl88S to fill skill vacancies. As at th8 end of 2023 the Charity seried 371 MS members and 338 Associale members. The Trustees wish to record their Wdteful thanks lo our volunte8rs and others who willingty donate their time and s8rvic8S to our cause. Their wonderful support ensures that the New Centre continues to provid8 car8 and support to members and will continu8 to do so for Ihe foreseeable future. The Trust8es would like the extend a spectfic thank you to the Frank Brake Charitable Tnjst, The Loveday Charitable Trust, Meads TrusL Edward Gostling Foundation and Thomas J Home Memorial TrusL Also finally a specific a rnention for Kent Social Enterprise Loan Fund for the loan and grant funds that have enable the redevelopment Wacher Suite lo help the charity greater maximise its ass81s. b. Public awareness The Ttustees and the Execlrtive Team continue to prrjnote awareness of the Centre within the local community. Publlc benefft The trustees have complied wtth Iheir duty to have regard to Ihe guldance on public benefit published by the Charfty Commlssion in exercising their powers or duties. The activities of the thatity are directsl to. providing significant supwrt for those with MS and other simllar conditions both through treatment and therapy, infomial advi￿ arxl peer supporL Any contribution made towards the running cos15 of the charity is at the discrelion of thé m8mber with MS and all MS Members have the opportunity lo benefit from the activities of the tharity without charge. The balants of the Nnning cost is subsidised through its fundraising and income g8n8ration activities. Page 3

KENT MULTIPLE SCLEROSIS THER￿py CENTRE LTD (A company Ilmlted by guarantee) TRUSTEES. REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023 Achlevements and perfomiance {continued) d. Achlevements and perforniance overvlew Kent MS Therapy Centre continues to extend lh8 scope of therapies on offer. A summary is shown below Th8rapy Data Total Total Distinct Distinct Attendances Dlstlnct MS Associate Attendees Attendees Attendees 302 123 179 255 140 115 Oxygen Therapy Complementary Therapies (ind. aoJpunctur8. massage. reflexology) Hydrotherapy Pool Therapies {hydrotherapy. aqua yoga. swimming) Physiotherapy (land based) therapies (physi0th8rapy. gym, Pilates) Couns811ing APS Therapy Podiaty Singing Group Therapy Other Total 2022 Total 5,469 2.255 2.224 170 87 83 2.016 201 124 77 227 215 207 205 187 13,005 11256 33 21 71 18 31 585 489 20 13 47 23 24 21 10 337 235 254 As we attract more Members with MS exlend our therapy offering the level of subsidy required to support our therapies incfeas8s. Fundraising and sustainable income generation becomes ever more important. e. Fundralslng and income generallon Restricted Funds Unrestricted Funds 2023 473.872 144,312 114,353 1.487 179 £734,203 Total Funds Total Funds 2023 97,260 2023 571.132 144,312 114.353 1,487 179 £831,463 2022 516,981 17,242 76,903 207 1,190 £612,529 Donations and legacaes Charifable activities Other trading activities Investments Oth￿ inGome Total income £97.260 Financial review Going concern After making appropriaie enquiries, lh8 Trustees have a reasonable expectallon that the Company has adequate resources to continue in operational existen￿ for the foreseeable future. For this reason. they continue to adopt the going cx)nc8m basis in preparing the financial statements. Further details regarding the adoption of the going concern basis ¢aD be found in the accounting policies. Page 4

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD {A company limited by guarantse) TRUSTEES. REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023 b. Reserves policy The charflable company has maintained a tight control on expenditure throughout the year. It seeks to maintsin a reserve account which is equivalent to 3 months running costs whilst recognising that after a challenging year, it will take time to build res8rves to this level. General review Incoming reSoU￿S for the year amounted to £831.463 (2022= £612,29) with expenditure totslling £756,958 (2022.. £700.761) resulting in a surplus of £74.505 (2022: deficit of £88.232). It is the Trustees intention to apply all funds receiv8d in any one year whilst maintaining an appropriate level of unrestricted reserv8s in aC￿rdaThCe with the policy. Revenue Fundin The charitable company continues lo be heavily reliant upon th)nations and fundraising for its inccme along with vital in￿rne from non-ms Oxygen Therapy. During 2023 the tharity welcomed the Parkinson's Centre for Integrated Therapy (PCIT) into th8 Centre. As a result of this collaboration. there was an increased income via hire of office space & therapy rooms, and also an inc¥eased expenditure for these thetapies and therapists. The collaboration wilh PCIT within the centre cam8 to an end in early 2024. Th8 charity is also grateful to its staff, therapists and volunteer5 who have assist8d with income generating aclivities. Restricted funds for specafic projects have been received during the year from the following sources: Reslricted funds received In 2023 Charlotte Marshall Charitable Trust Kent Communty Foundation Sir Jules Thom Charitable Trust William Brake Foundation Henry Smith Charity The James Tudor Foundation The February Foundation F B Coales No. 4 (Famity) Tntst The Big Give 2023 individual donations The 819 Give 2022 Champion Funder Roger De Haan Charitab18 Trust Kent Community Foundation M&G Ccmmunity Fund Whitehead Monckton Charitable Foundation Souter Charitab18 Trust Beerling Foundation Cantiacorum Foundation The Sir James Roll Charilable Trust The Grace Trust Anonymou5 donor Kent Social Enterprise Loan Fund Wesffield Health Giving Back Committee Amount Pur se £453 Oxyg8n th8rapy £4.000 Oxyg8n th8rapy £3,000 Physio- and hydrotherapy £15.000 Physio- and hydrotherapy (Hydrotherapy) £5,1)00 Physio- and hydrotherapy £5.000 Physio- and hydrotherapy £5.000 Physic￿ and hydrotherapy £3.000 Physio- and hydrotherapy £6.020 Physiotr and hydrotherapy £1.750 Complomentary therapies £7.500 Complementsry therapies £3.000 Complementary therapi85 £3.000 Complementsry therapies (Massage and reflexology) £475 Cornplementary therapies {Massage and reflexology) £3,000 Counselling (Mental Health Support Programrne) £1.250 Counselling {Mental Health Support Programme) £1.500 Coun5elling (Mental Health Support Programme) £1.250 Counselling (Mental Health Support Programme) £1,000 Counselling (Mental Health Support Programme) £3.000 other- Beao)n CRM £23.000 Other- Wacher Suite Redevelopment £1.062 Other- Therapy couch Page 5

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD (A company Ilmlted by guarantee) TRUSTEES, REPORT (CONTINUED} FOR THE YEAR ENDED 31 DECEMBER 2023 Slructurel governance and management Constitutlon The company is registered as a charitable company limited by guarantee and was set up by a Memorandum of Association on 5 March 1993. The company is a registered thartty. number 801382. The principal object of the company is the provision of s8rvices and support to aid 2nd improve the Condition of those living with Muttiple Sclerosis. b. Methods of appointment or ekctlon of Trustees Trustees are appointed or reappointed at the Company Annual General Meeting and, under the Articles of Association, hold office for a temi of three years and are eligible for re-election for a maximum of three tenns wlth the option to extend this in special crcumstances. ¢. Organisatlonal structure and decision4naking policies The board of trustees is responsib￿ for govemance of the charity and generally me8ts every month. The board sets th8 strategic direction and policy for the charity. agrees an annual budget. and monttots P8rformance against it. The day-to4lay rnanagement of th8 Centre is the responsibilty of the Executive team. d. Risk managemont The Trustees have assessed the major risks to ￿1¢h the company is exposed. those related to the operations and fInan￿S of the company and are satisfied that systems and pro(%dures are in place to mitigate exposure to the major risks. The support we have had from our donors and sponsors has been unparallel8d and very much appreciated; the centre remains in reasonable financial health Con￿(jenng the challenges imposed on fund raising. We remain confident as Trustees that Ihe centre will continue to Ir￿)roVe and grow to better support tha livas of people living with MS in K8nL Page 6

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD IA company limited by guarantee) TRUSTEES. REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023 Future developments Kent MS Therapy Cenlre conlinues to work to make more people with MS in Kent aware of the Centr8 and understand how it can help. Activities towards Ihis aim include collaboration with existing MS support groups such as the MS Soaety. MS Trust. profile raising amongst NHS specialised groups and clinicians and more effective use of social media, along with continued retalionships with mainstream media. Our strategy to 2025 is buitt on three pillars: Improve our financial sustainability by maximising the income from the Centr8's building. alongside a fundraising strategy focusing on multi-year donations. Deliver support for more Peopla with MS (and other conditions) acros5 Kent by delivering therapies from other locations. in addition to the Centre in Canlerbury. Become recognis8d as a Centre of Excellence: providing leadership in the provision of ￿re and being recognised as an organisation that continues to leam by seeking out knovAedge and expertise in the der community. new The executive team have made progress on all 3 pillats of our strdlegy during 2023. We hav8 Wa￿ed dosely in 2023 wth the University of Kent and the Pathnson's Centre for Integrated Therapy. the latter being based in the Centre from April 2023 with the aim of working more dosety lo benefit a wder group of people living with neurological conditions. We have akn started a fruitful working relationship with Canterbury Christ Church University to develop our moniioring and evaluation capacity. Our Mission 'Improving the lives of those living with MS in Kenr The Centre aims to radically improve the Ilves of those with Muftlple Sderosis, their families and those who care for Ihem. We aim to: Provide a range of complem8nlary therapies and specialist clinics, Give advi￿. support and infomation to those living with MS. their ￿YerS and families, in an environment which encourages mutual support and friendship, Be a Centre of Excellence vthich enables s8if4nanagement of the condttion, The Centre welcomes people throughout Kenl. Page 7

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD (A company limited by guarantee) TRUSTEES. REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023 Statement of Trustees. responslbllltles The Trustees (who are also the directors of the Company for the purposes of company law) are responsible for preparing the Trustees, report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accouniing Practice)- Company law require5 the Trustees to prepare financial statements for each financial year. Under wfflpany law. the Trustees must not approve the financial statements unless thay ara satisfied that they give a true and fair view of the state of affairs of the Company and of its incoming resources and application of resources, including its incom8 and expenditure. for that period. In preparing Ihes8 finanaal statements. th8 Trustaes are reqUi￿d to: select suttsble accounting policies and then apply them consistenlly. obseNe the methods and principles of the Charities SORP {FRS 102}; make judgments and accounting estimates that are reasonable and prudent: state whether applicable UK Accounling Standards (FRS 102) have been followed. subject to any material departures disclos8d and explained in the financial statements,. pr8pare the finanoal stalements on Ihe going con￿rn basis unless it is inappropriat8 to presume that the Company will continue in ￿siness. The Trustees are responsible for k*ping adequate accounting records that are SLsfficient to show and explain the Company's transactions and disclose with reasonable accuraw al any time the financial position of the Company and enable them to ensure that Ihe financial statements comply the Companies Act 2006. They are also responsible for safeguarding the assets of the Company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. Approved by order of th8 m8mbers of the board of Trustees on 24 July 2024 and signed on th8ir b8half by: MrJ (Cha mer of Trustees) Mrs J Tompkins Page 8

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD (A company limited by guarantee) INDEPENDENT EXAMINER'S REPORT FOR THE YEAR ENDED 31 DECEMBER 2023 Independent examinerfs report to the Truste85 of Kent Multiple Sclerosis Thorapy Centre Ltd I'lhe Company.) I report to the charity Trustees on my examination of the accounts of the Company for the year ended 31 December 2023. Responsibllltles and basis of report As the Trustees of the Company (and its direclors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with Ihe requirements of the Companies Act 2006 ('the 2006 Act'}. Having satisfied myself that the accounts of the Company are not required to be audrted under Part 16 of the 2006 Act and are eligible for indepeThJent examination. l ￿pOrt in respect of my examination of the Company's accounls carried out under seGtion 145 of the Charities Act 2011 (Ihe 2011 Acy). In catrying out my examination I have followed the Directions given by the Charty Commission under section 145{5){b) of the 2011 Act. Independent examinerfs ststsment Since the Companvs gross income exceeded £250.000 y￿r examiner must be a member of a body listed in section 145 of the 2011 Act. I confirm that l am qualified to undertake Ihe examination because l am a member of {enter body here), wh￿h is one of the listed bodies. I have completed my examination. I C￿nfirM that no matters have come to my attention in connection with the examination giving me cause to believe: accounting records were not kept in resp8ct of the Company as required by section 386 of the 2006 Act., or the accounts do not accord with those record4 or the accounts do not comply with the accounting requirements of sedion 396 of the 2006 Act other than any requirement that the accx)unts give a Irue and fairf view which is not a rnatter considered as part of an independent examination: or the accounts have not been prepared in accordance with the methods and principles of the Statement of R8￿Mmended Practice for accounting and reporting by charities [applicable to charities preparing their a¢¢ounts in accordanc• with the Financial Raporling Slandard applicable in Ihe UK and Republic of Ireland (FRS 102)]. I have no concems and have come across no other matters in connection with the examination lo which att8ntion should be dravm in this report in order to enable a proper understanding of the accounts to be reached. This report is made solety to the Companys Trustees, as a body. in accordance wlth Part 4 of the Charlties (Accounls and Reports) Regulations 2008. My work has been undertaken so that I might state to the Companvs Trustees thos6 matters l am required to state to Ihem in an Independent examinerfs report and for no other purpose. To the fullest extent pemiitted by law, I do not accept or assume responsibility to anyone other than the Company and Company's Trustees as a body, for my work or for this reporL Signed: Dated: 30 Roland Pary FCA Magee Gammon Chartered Acojuntants Page 9

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD (A company limited by guarantee) STATEMENT OF FINANCIAL ACTMTIES {INCORPORATING INCOME AND EXPENDITURE ACCOUNT) FOR THE YEAR ENDED 31 DECEMBER 2023 Restricted Unrestricted funds funds 2023 2023 Total funds 2023 Total funds 2022 Income from: Donations and legacies Charitab18 acknvities Other trading activities Investments Other income 97,260 473,872 144,312 114,353 1.487 179 571,132 144,312 114,353 1,487 179 516,981 17,242 76,903 207 1,196 Total income 97.260 734,203 831,463 612,529 Expendilure on: Raising funds Charitable aclivities 130,927 543,838 130,927 626.031 130,300 570.461 82.193 Total expendituro 82.193 674,765 756.958 700.761 Net In¢omel(expenditure} Transfers between funds 15,067 (27.433) 59,438 27,433 74,505 (88,232) 19 Net movement in fvnds (12,366) 86,871 74.505 (88.232) Reconciliation of funds: Total funds brought forNard Net movem8nt in funds 35.170 (12.366) 1.457,264 86,871 1,492.434 74505 1.580.666 (88,232) Total funds carried forward 22.804 1.544,135 1,566.939 1.492.434 The Statement of financial activities indudes all gains and losses recognised in the year. The notes on pages 13 to 30 fomi part of these financial statements. Page 10

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD (A company limited by guarantee) REGISTERED NUMBER= 02339750 BALANCE SHEET ASAT 31 DECEMBER 2023 2023 2022 Note Fixed assets Tangible assels Current assets 14 1 A67,241 1,394,078 Debtors Cash at bank and in hand 15 15.311 163.732 3.859 103,342 179,IM3 707,201 Cr8ditors: amounts falling due within ¢)ne year 16 (21,870) (8.845) Net Cur￿nt assets 157,173 98,356 Creditors: amounts falling due after m(xe than on8 year 17 (57.475) Total net assets 1.566.939 1.492,434 Charity funds Restricted funds Unrestricted funds 19 22,804 1,544.135 35.170 1.457.264 19 Total funds 1,566,939 1.492.434 The Company was entitl8d to ex8mption from audit under section 477 of the Companies Act 2006. The members have not required the company to obtsin ￿ audit for Ihe year in qu8stion in accordan￿ with section 476 of CompaTMes Act 2006. The Trustees acknowledge their responsibilities for complying with the requirements of the Act wth ￿Spect to accounting records preparation of financial sLgtements. The finanrAal statements have been prepared in accordance wilh Ihe provisions applicable to entities subject to the small companies regim8. Th8 financial stat8m8nts V￿re approved and authorised for issue by the Trustees on 24 Juty 2024 and signed on their behalf by- MrJ (Ch mmer of Trustees) Mrs J Tompkins The notes on pages 13 to 30 form part of these financial statements. Page 11

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD (A company limited by guarantee) STATEMENT OF CASH FLOWS FOR THE YEAR ENDED 31 DECEMBER 2023 2023 2022 Cash flows from operating activities N8t cash used in operating activities 106,153 (51,98Q) Cash flow5 from investing activities Purchase of langible fixed assets (113,484> (6, 759) Net cash used in investing activities {113,484) (6,759) Cash flows from flnanclng actlvltles Cash inflows from new borrowng Repayments of bomwing .000 {9.279) Net cash provided by flnancing actlvltles 67.721 Change In cash and equivalents in the year Cash and cash equivalents at the beginning of the year 60.390 {58,739) 162,081 103,342 Cash and cash equlvalents al the end of the year 163.732 103.342 The notes on pages 13 to 30 forni part of these financial statements Page 12

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD (A company Ilmited by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023 General inforrnatlon The Kent Mulliple Sderosis Therapy Centre Limited is a private company. limitad by guarantee. incofporated in England and Wales. The company registralion numb8r is 02339750. The registered office adddr8ss is Bradbury House. Merton Lane (North), Canterbury. Kent. CT4 7DZ. Accounting pollcles 2.1 Basis of preparation of financial statements The financial ststements have been prepared in accordan￿ with the Charities SORP (FRS 102) - Accounting and Reporting by Charities: Statement of Recommended Practice applicable tc charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019), the Financaal Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006. Kent Multiple Sclerosis Therapy Centre Ltd meets the defjnttion of a public benefrt entity under FRS 102. Assets and liabilities are initially recognis8d at historical cost or transaction value unless otherwise stated in the ￿le¥an1 accounting policy. 2.2 Income All income is re(x)gnised once the Company has entiuement to the In￿Me, It Is probable that the income wlll be re￿Ived and the amount of income r￿e1Vable can be measured reliably. The recognition of income from legacies is dependent on estsblishing entitlemen( the probability of re￿ipl and the ability to estimate with SLrfficient accuracy Ihe amount re￿¢vable. Evidence of entitlement to a legacy exists when the Company has sufficient evidence that a gift has been left to them {through knowledge of the exislence of a valid will and the death of lh8 b8n8factor) and the executor is satisfied that the property in question will not be required to satisfy claims in the estate. Receipt of a legacy must be recognised when it is probable that it will be received and the fair value of the amount receivable. which will gen8ralty be the expecled cash amounl to be distributed lo the Company. can be reliabty rneasured. Grants are induded in the Statement of firkgncial activltles on a receivable basis. The balan￿ of income reeetved for specific purposes bul not expended during the period is shown in tho ralavant furK15 on the Balan￿ sheet. Where income is re￿Ned in advance of entitlement of reixipt. its recognition is deferred and induded in creditors as deferred income. Where entitlement occurs before income is re￿ived. the income is accwed. Income tax recoverable in relation lo inveslmenl inc4Jme is recognised at the tim8 th8 inv8Stment income is receivable. Other income is recognised in the period in whith it is receivable and to the extent the goods have been provided or on completion of the servic8. Page 13

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD {A ￿MpanY limited by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023 Accountlng policies {¢ontEnued) 2.3 Expenditure Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settletnenl and the amount of the obligation can be measured reliably. Expenditure is classified by activity. The costs of eath activty are made up of the total of direct costs and sharad costs. induding support costs involved in undertaking each actlvity. Dlre¢t costs attributable to a single acttvity are allocated directly to that adivity. Shared costs which contribute to more than one activity and support I￿sts which we not attributable to a single activity are apportioned be￿een those activities on a basis consistent with the use of resources. Central staff (x)sts are allocated on Ihe basis of time spent. and depreciation charges allocated on the portion of the asset's use. Expenditure on charitab18 activities is incurred on directly undertaking the activities which further the Companys objectives, as Y￿11 as any assocaated supporl costs. All expenditure is indusive of irrecoverdble VAT. 2.4 Interest receivabl8 Interest on funds held on deposit is included when receNable and the amount can be measured reliably by the Company- this is normally upon nolification of the interest paid or payab18 by the institution with whom the funds are deposited. 2.5 Tangible fixed assets and depreciation Tangible fixed assets costing £NIL or more are (Zpita￿Sed arKI re￿n[s8d ￿en future economic benefits are probable and the cost or value of the asset can b8 m8asur8d reliably. Tangible f￿ed assets are initially recognised at cosL After recognition. under the cost model, tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impainnent k)sses. All oysts in(JJrred to bring a tanglble fixed asset into its intended working condition should be included Sn the measurement of cosl. Depreciation is charged so as to allocate the cost of L￿gibl6 fix8d assets less their residual valu8 over their estimated useful INes, as below. Deprecsation is provided cm the followng basis: Buildings Plant and machinery Ftxtures and fittings Compuier equipment 2% straight line basis 1 00/0 straight line basis 300/0 reducing balanca basis 33Yv straight line basis 2.6 Debtors Trade and other debtor5 are recognised at the settlement amount after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due. 2.7 Cash at bank and In hand Cash at bank and in hand indudes cash and short-terni highly liquid investments with a short malurity of ttiree months or less from the date of acquisition or opening of th8 d8F)OSit or similar account. Page 14

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD (A company Ilmited by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023 Accounting policles (continued) 2.8 Liabilit185 and provisions Liabiliti8s are recognised when there is an obligation at the Balance sheet date as a r8sun of a past event. it is probable that a Iransfer of economic benefrt will be required in settlement. and the amount of the settlement can be estimated reliabty. Liabilities are recognised at the amount that the Company anticipates it will pay to settle the debt or the amount it ha5 received as advanced payments for the goods or services it must provide. Provisions are measured at the best estimate of the amounls raquired to setue the obligation. Where the effect of the time value of money is material, the provision is based on the present value of those amounts. discount8d al the pre-tax discount rate that reflects the risks specific to the liability. Th8 unwinding of the discount is recognised in the Statemenl of financial activities as a finance Gost. 2.9 Financial instrum•nts The Company only has financial assets and financial Ilabllities of a kind thal qualify as basic financi81 instruments. Basic financial instruments are initially recognised at transaction value and subsequenlly measured at their settlement value the ex(xption of bank loans which ar8 subsequently measured at amortised cost using the effective interest rnethod. 2.10 Operating loases Rentals paid under operatino leases are charged lo the Statem8nt of finanaal activities on a straight4in8 basis over the lease tem). 2.11 Pensions The Company operates a defined contribution pensi(m scheme and the pension charge represents the amounts payable by the Company to Ihe fund in respect of the year. 2.12 Fund accounting General funds a￿ unrestrrcted fuTJds whith are available for use at the discretion of the Trustees in furtheranGe of Ihe general objeGlives of the Company an¢J which have not been designated for other purposes. Designated funds comprise unrestricted funds Ihal have been set aside by the Trustees for particular purposes. The aim and use of each designaled fund is set out in the notes to the financial statements. Restricted furKls are funds whith are to be used in accordance sp8afic restrictt.ons imposed by donors or which have been raised by the Company for particular purposes. The costs of ralslng and administering sudi funds are charged against the speufic fund. The aim and use of each restricted fund is s8t out in the notes lo the financial statements. Investment income. gains and losses ar8 allocated to the appropriate fund. Page 15

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD (A company limited by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023 Incomo from donations and lega¢les Restricted Unrestrfcted funds funds 2023 2023 Total funds 2023 Total funds 2022 Donations Legacies Grants Treatrnent donations 9.020 53,031 66.842 152.533 201.466 62.051 66,842 240,773 201,466 96.050 37,394 230.119 153.418 88,240 97.260 473.872 571.132 516,981 Total 2022 132.275 384.706 516,981 Income from charitable acllvllles Unrestricted funds 2023 Total funds 2023 Total funds 2022 Membership subscriptions R8ntal income 25.675 118,637 25.675 118.637 17,242 144.312 144,312 17.242 Total 2022 17.242 17.242 Page 16

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD (A company limited by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023 Income from other trading acttvities Incorne from fundralslng events Restrlcted Unrestrlcted funds funds Total funds Total ftinds 2023 2023 2023 2022 Fundraising events Sale of goods and literature 67.999 46.354 67.999 46,354 52,276 24.627 114.353 114.353 76.903 Total 2022 300 76,603 76,903 Investment income Unrestricted fvnds 2023 Total funds 2023 rotal funds 2022 Investrnent income 1,487 1A87 207 Total 2022 207 207 OthÈr Ineomlng rèsources Unrestricted funds 2023 Total funds 2023 Total funds 2022 Solar panels 179 179 1, 196 Total 2022 1.196 1.196 Page 17

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD (A company limtted by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023 Expendlture on raislng funds Fundraising exp8nses UnrestriGted funds 2023 Totsl funds 2023 Total funds 2022 Allocated ￿ntrallY incurred fundraising and goveman costs 130,927 130,927 130.300 Total 2022 130,300 130,300 Analysi5 of expenditure on charitable actlvities Summary by fund type Restrlcted Unrestrlcted funds funds 2023 2023 Total 2023 Total 2022 Chartiable activities 82.193 543.838 626,031 570.461 Total 2022 98,991 471.470 570,461 10. Analysis of expenditure by activitses Activltle5 undertaken dlreclty 2023 Support ¢osts 2023 Total funds 2023 Total funds 2022 Charitable activities 330.204 295.827 626.031 570.461 Total 2022 265.867 304.594 570.461 Page 18

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD {A company limlted by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023 10. Analysis of expenditure by activities {continued) Anatysis of direct costs Total funds 2023 Total fvnds 2022 Activities 2023 Wages and salaries Maintenance of equipment and buildings Oxygen Physiotherapy. reflexology and counselling Training courses Depreciation Govemance costs 108.341 19,000 25.138 133.537 1,587 40,321 2.280 108.341 19.000 25.138 133.537 1.587 40,321 2,280 91,611 36,300 18,639 70,918 4.843 39.326 4,230 330,204 330,204 265,867 Total 2022 265.867 265,867 Page 19

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD (A company limited by guarantee NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER2023 10. Anatysis of expenditure by aCtI￿tieS (continued) Analysis of support costs Total funds 2023 Total fvnds 2022 Activities 2023 Wages and salaries Trav811ing expenses Cleaning and general costs Printing. postage. Stalionery and copies Advertising and recruitment Telephone Insurance Rent and rates Light and heal Li￿n￿5 and subscriplions Bank charges CompLrter and website expenses Sundry expenses Loan charges and interest Professional fees 184.235 925 24.460 2,195 2.385 7,413 6.877 1.000 30,219 10.654 3.272 12,456 1.070 6.506 2.160 184,235 925 24,460 2,195 2,385 7,413 6,877 1,000 30,219 10,654 3,272 12,456 1,070 6,506 2,160 211,548 1.333 22.023 1,094 5,910 6,522 7.431 1.000 25.160 10.283 3.475 8.039 776 295.827 295,827 304.594 Total 2022 304.594 304,594 Anaty3is of fundraising costs 2023 2022 Wages and salaries Fundraising expendiiure Cost of goods sold 97.282 30.502 3.143 96,924 31.225 2,151 130.927 130,300 Page 20

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD (A company limitsd by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023 11. Indopendent examlner's remuneration 2023 2022 Fees payable to the Company's independent examiner for the independent examination of the Company's annual accounts 2,280 1,920 12. staff costs 2023 2022 Wages and salaries Social security costs Contribution to defined contribulion pension schemes 357.374 24,758 7,726 364.465 27,425 8.193 389.858 400.083 The average number of persons employed by the Company during the year was as follows: 2023 No. 2022 Employ88S 17 18 The number of employees ththose employee benefits (excluding employer pension costs) exceeded £60.000 was: 2023 2022 In th8 band £60.(K)1- £70.000 The key management personnel of the Charity comprise the TNstees and the Chief ExecutNe. The total employee beneffits of the key management personnel of Ihe Charity was £62,132 (2022: £61.611). 13. Trustees. remuneration and expenses During the year. no Trustees received any remuneration ￿ other benefrts (2022- £NILJ. During the year ended 31 December 2023. no Trustee expenses have been incurred (2022- £NIL). Page 21

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD (A company limited by guardntÈe} NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER2023 14. Tangible fixed assets Long4erm leasehold property Plant and Fixtures and machlnery fittings Computer equipment Totsl Cost or valuatlon At 1 January 2023 Additions 1.585,775 98.663 139.495 6.967 73,10S 2,868 47.420 4.986 1,845,795 113.484 At 31 December 2023 1.684,438 146,462 75,973 52A06 1,959,279 Depreciation At 1 January 2023 Charge for the year 236,797 21.930 110.755 11,182 56,971 3,275 47.194 3,934 451,717 40,321 At 31 De￿mber 2023 258,727 121,937 60,246 51,128 492,038 Net book value At 31 D8cember 2023 1A25,711 24.525 15.727 1.278 1,467.241 At 31 De￿rnber 2022 1,348,978 28.740 16. 134 226 1,394,078 15. Debtors 2023 2022 Due within one year Trade debtors Prepayments and accrued income 4,765 10,546 t,035 2,824 15,311 3,859 Page 22

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD (A company limited by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023 16. Creditors: Amounts falling due wSthln one year 2023 2022 Other loans Trade creditors Other creditors Accruals and deferred income 13.326 5,574 970 6,462 641 1, 742 2,000 21.870 8,845 17. Credltors: Amounts falllng due after more than one year 2023 2022 Other loans 57,475 18. Flnanclal instruments 2023 2022 Financial assets Financial assets measured at far value through income expenditure 163,732 103.342 Financial assets measured at fair value through income and expenditure comprise of cash at bank and in hand. Page 23

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD (A company limited by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER2023 19. Statement of funds Statement of funds - current year Balance at 31 December Balance at 1 January Transfers inlout 2023 Income Expenditure 2023 Unrestrlcted funds Designated funds Designaled Funds 1.394.078 73,163 1,467,241 General funds General Funds 63,186 734.203 (674.76S) 145,730) 76,894 Total Unrestricted funds 1.457.264 734,203 (674,765) 27,433 1,544,135 Restrlcted funds Cofflplementary Therapies Couns811ing Other Oxygen Therapy Physiotherapy and Hydrotherapy 4.900 1.718 6,379 1.982 15.725 8,01)0 27,062 4,453 (20,625) (5,718) (7.150) (6A35) 4,000 2.229 (24,062 20.191 42,020 (42,2651 (3,371 16,575 35.170 97,260 (82.193) (27,433> 22,804 Totsl of funds 1,492,434 831,463 {756.958) 1,566,939 Page 24

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD (A company limited by guarant8e} NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023 19. Statement of funds (contlnued) Com lement era ies Anonymous Trust - The Big Give 2022 Champion Funder donated £1.750. This was utilised during the year. Kent Community Foundation donated £3.000. This was utilised during the year. M&G Community Fund donated £3.OlJ]. This was utilised during the year. Roger De Haan Charitable Trust donated £7,$00. This was utilised during the year. The balan￿ of funds donated last year by The Big Give 2022 individual donations of £4,900 were utilised during the year. Whilehead Monckton Charitabla Foundation donated £475. This was utilised during the year. Counsellin Beerling Foundation donated £1.250. This has been carried f(xward. Cantiacorum Foundation donated £1.S(K). Of this. £1.000 was utllised durlng the year and £500 has been Carried fomard. SoLrter Charitable Trust donated £3.000. This y￿S utilised during the year. The Grace Trust donated £1.000. This has been carried forward. The balance of funds donated last year by The fvlrs Smith and Mount Trust of £1.718 were utilised during the year. The Sir James Roll Charitable Trust donated £1.250. This has been carried fo￿ard. Other An anonymous individual (k)nated £3,000 towards Beacon CRM. Of this, £771 VRS utlllsed durlng the year and £2,229 has been Ca￿led fOr￿Erd. Kent Social Enlarprise Loan Fund donated £23,000 towards the Wach8r Suite redevelopment. This was utilisÈd during the year. The balance of fijnds donated last year by NFU toward5 the Parkinson's project of £6.379 were utilis8d during the year. Westfield Health Giving Back Committee donated £1,062 towards a therapy couch. This was utilis8d during the year. en Thera Ch8rlotte Marshall Charitable Trust donated £453. This was utilised during the year. Kent Community Foundalion donated £4.000. This was utilised during the year. The balance of funds donated ￿st year by The Philip Connie Phillips Foundation of £1.982 were utilised during thè year. Ph si0th8ra and H drothera F 8 Coales No.4 (Family) Trust donated £3.000. This was ull￿Sed durtng th8 y8ar. Henry Smith Charity donated £5,000. This was utilised during the year. Page 25

KENT MULTIPLE SCLER051S THERAPY CENTRE LTD (A company limited by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023 19. Statement of funds (continued) Of the balance of funds donat8d last year via the Mike Butcher Donation, £8,033 was utilised during the year and £10,555 has been carried forward. Sir Jules Thom Charitable Trust donated £3.000. This was utilised during the year. The Big Give 2023 individual donations donated £6.020. This has been carried forward. The February Foundation donated £5.000. This was utilised during the year. The balan￿ of funds donated lasl year by The Henry Smith Charity of £965 were utilised during the year. The James Tudor Foundation donated £5,IX)O. This was utilised during the year. The balance of funds donated last year by The Roger De Haan Charitable Trust of £638 were utilised durtng the year. William Brake Foundation donated £15.000. This was utilised during the year. Page 26

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD (A company limited by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023 19. Statoment of funds (contlnued) statement of funds - prior year Balance at 31 D8c8mb8r 2022 Balance at l January 2022 Transfers inlout Income &penditure Unrestrfcted funds Designatsd funds Designated Funds 1.426,645 (32,567) 1,394,078 General funds General Funds 145.676 479.954 (601, 770) 39,326 63,186 Total Unrestrlcted funds 1.572.321 479.954 (601, 770) 6. 759 1.457.264 Restricled funds Complem8ntsry Therapies Core Costs Counselling MS Clid( and Connect Other Oxygen Therapy Physiotherapy and Hydrotherapy 7,400 1,700 6,000 (2.500) (1, 700) (5,617) (4. 750) (4.990) (22.820) 4,900 1.335 750 1,718 11.369 23.550 6,379 1,982 1.252 4008 78,556 (56.614) (6. 759) 20.191 4345 132,575 (98.991) (6. 759) 35.170 Total of funds 1.580.666 612.529 (700. 761) 1.492.434 Page 27

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD (A ￿rnpanY limited by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023 20. Summary offunds Summary of funds - currenl year Balance at 31 December 2023 Balance at 1 January 2023 Transfers inlout Income Expenditure Designated funds General funds Restricted funds 1.394.078 63.186 35.170 73.163 (45,730) (27.433) 1,467,241 76,894 22,804 734.203 97,260 (674.765) (82.193) 1.492.434 831,463 (756.958) 1,566.939 Summary of funds - prior year Balance at 31 Decemb8r 2022 Balanc8 at l January 2022 Transfers in/out Income Expenditu Designated funds General funds Restricted funds 1.426.645 145.676 8.345 (32,567) 1,394,078 39,326 63, 186 (6, 759) 35,170 479.954 132.575 (601, 770) (98,991) 1.580.666 612,529 (700, 761) 1,492,434 21. Anatysls of net assets between funds Analysls of net assels between funds - cumint year Restricted Unrestrlcted funds funds 2023 2023 Total funds 2023 Tangible fixed assets Current assets Creditors due within one year Creditors du8 in mora than one year 1,467,241 156.239 (21.870) (57.475) 1,467,241 179,043 {21,870) 157.475) 22.804 Total 22.804 1.544,135 1,566.939 Page 28

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD (A company limited by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023 21. Anatysis of net assets between funds (continued) Anatysis of net assets between fvnd5 - Pritx year Restncted Unrestn'cted fvnds fvnds 2022 2022 Total funds 2022 Tangible fixed assets Current assets Creditors du8 Within one year 1.394.078 72.031 (8.845) 1,394,078 107,201 (8.845) 35.170 Total 35.170 1.457.264 1.492.434 Reconciliation of net movement in funds to net cash flow from operating activities 2023 2022 Net incomelexpenditure for the year (as per Staternent of Financial Activtties) 74S05 (88.232) Adjustments for. Depreciation charges Increase in debtors Increasel(decrease) in (¥editOTS 40.321 {11,452> 2.T79 39.326 (1.480) {1.594) Net cash provlded byllused in) operating activitias 106.153 (51.980) 23. Analysls of cash and cash equivalents 2023 2022 Cash in hand 163,732 103.342 Total cash and cash equivalents 163,732 103,342 Page 29

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD (A company limlted by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023 24. Anatysis of changes In not debt At1 January 2023 Cash flows other non- At31 cash DeGember changes 2023 Cash at bank and in hand Debt due within 1 year Debt due after 1 year 103,342 60,390 (13,326) (60,555) 163.732 (13,326) (57A75 3.080 103.342 113,491) 3,080 92,931 25. Penslon Commitments The charity operates a defined cnntribution pension scheme. The ass8ts of the scheme are hekl separalely from Ihose of the charity in an independenlly administered fund. The pension c(k8t d)arge represents contributions payable by the charty to the fund and amounted to £7,726 (2022 - £8,193). Contributions totalling £nil (2022 £nil) w8r8 payable to the fund at the balance sheet dat8 and are included in credrtors. 26. Operating lease commitments At 31 December 2023 the Company had commitments to make fijture mlnimum lease payments under non-cancellable operating leases as follows: 2023 2022 Not later than 1 year Later than 1 year and not later than 5 years Later than 5 years 1.000 4,000 115,000 i.ooo 4,000 116.000 120,000 121.OOQ Members. liability Each member of the charitable company undertakes to o)ntribute to the assets of the company in the event of it being wound up while helshe is a member, ￿ within one year after helshe ceases to be member. 5uth amount as may be required. nol exceeding £1 for the d8bts and liabiliti8s contracted before they cease to be a member. 28. Related party transa¢ttons The Company has not entered into any related party transaclion during the year. nor are there any outstanding balances owirwJ behyeen r81at8d parties and the Company at 31 Decembér 2023. Page 30